Studies performed in conditional-knockout mice treated with specific carcinogenenic compounds to promote inflammation-induced colitis-associated cancer, have shown that the inactivation of the nuclear factor κ B (NF-κB) signaling in tumor infiltrating inflammatory cells results in attenuated colon cancer formation (49). The gene discussed is NFKB1; the disease is neoplasm.